<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E91EA92B-76A4-4BA2-BDB0-4978BC6F7E30"><gtr:id>E91EA92B-76A4-4BA2-BDB0-4978BC6F7E30</gtr:id><gtr:name>QUANTUMDX Group Limited</gtr:name><gtr:address><gtr:line1>International Centre for Life</gtr:line1><gtr:line2>Times Square</gtr:line2><gtr:postCode>NE1 4EP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E91EA92B-76A4-4BA2-BDB0-4978BC6F7E30" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>E91EA92B-76A4-4BA2-BDB0-4978BC6F7E30</gtr:id><gtr:name>QUANTUMDX Group Limited</gtr:name><gtr:address><gtr:line1>International Centre for Life</gtr:line1><gtr:line2>Times Square</gtr:line2><gtr:postCode>NE1 4EP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>752685.0</gtr:offerGrant><gtr:projectCost>1970228.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B1AFB6F8-9081-4C45-BBC2-0CDEE54054A5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>B1AFB6F8-9081-4C45-BBC2-0CDEE54054A5</gtr:id><gtr:name>Surescreen Diagnostics Limited</gtr:name><gtr:address><gtr:line1>1 PRIME PARKWAY , DERBY</gtr:line1><gtr:city>DERBYSHIRE</gtr:city><gtr:postCode>DE1 3QB</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>140736.0</gtr:offerGrant><gtr:projectCost>234560.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>363797.0</gtr:offerGrant><gtr:projectCost>363797.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>0.0</gtr:offerGrant><gtr:projectCost>0.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/32D7DA94-40C7-412A-8C24-F50FB4EC413C" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>32D7DA94-40C7-412A-8C24-F50FB4EC413C</gtr:id><gtr:name>Magna Parva Limited</gtr:name><gtr:address><gtr:line1>2 Meridian South
Meridian Business Park</gtr:line1><gtr:city>Leicester</gtr:city><gtr:postCode>LE19 1WY</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>161603.0</gtr:offerGrant><gtr:projectCost>269339.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AAE4450B-FECC-4E9F-B02A-BD099D02E6CE" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>AAE4450B-FECC-4E9F-B02A-BD099D02E6CE</gtr:id><gtr:name>Leaders in Oncology Care Limited</gtr:name><gtr:address><gtr:line1>242 MARYLEBONE ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1 6JZ</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>0.0</gtr:offerGrant><gtr:projectCost>0.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DFFF5314-A124-4D1F-8EF4-8AA6D8233CBB"><gtr:id>DFFF5314-A124-4D1F-8EF4-8AA6D8233CBB</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:surname>Peat</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=101378"><gtr:id>D72187B0-4356-498C-AF37-E25CDE6CB424</gtr:id><gtr:title>Q-CANCER: development of a sample to result device for low cost, rapid tumour profiling</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>101378</gtr:grantReference><gtr:abstractText>This project is concerned with the development of a fully integrated, low test cost, sample to result medical device that will enable a histopathologist (or a technician) to perform multiplex genotyping and tumour staging &amp;amp; profiling, within minutes, from formalin fixed &amp;amp;/or fresh tissue samples, providing a molecular adjunct to a histopathologist's standard practice. The device will automate sample prep &amp;amp; DNA sequencing at the press of a single button, following the introduction of a sample. The tissue sample is processed using a number of novel &amp;amp; innovative but proven microfluidic and nanotechnologies that allow for massive multiplexing potential. The device will enable fast turnaround of high quality genotyping that integrates with established clinical practice . Furthermore, the ability to rapidly profile &amp;amp; stage a tumour or identify genetic mutations will lead to improvements in patient outcomes, reduce patient anxiety &amp;amp; result in cost savings in treatment programmes.</gtr:abstractText><gtr:fund><gtr:end>2016-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2013-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1418821</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">101378</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>